These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11301629)

  • 1. [Gestagen supplementation].
    Ims L
    Tidsskr Nor Laegeforen; 2001 Feb; 121(5):629-30. PubMed ID: 11301629
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gestagen supplementation to estrogen therapy in climacteric].
    Iversen OE
    Tidsskr Nor Laegeforen; 2001 Jan; 121(1):82-3. PubMed ID: 12013622
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of initial gestagen treatment on bleeding patterns in postmenopausal women receiving continuous combined hormone replacement therapy.
    Büyük E; Durmuşoğlu F; Dökmeci C
    Menopause; 1999; 6(2):156-60. PubMed ID: 10374223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postmenopausal hormone replacement therapy and cardiovascular disease].
    Høibraaten E
    Tidsskr Nor Laegeforen; 2002 Jun; 122(16):1564-5. PubMed ID: 12119783
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of estrogen and gestagen substitution in peri and postmenopause].
    Birkhäuser M
    Praxis (Bern 1994); 1997 Jan; 86(5):125-8. PubMed ID: 9064729
    [No Abstract]   [Full Text] [Related]  

  • 8. [Difficult decisions on estrogen treatment of women with coronary diseases].
    al-Khalili F
    Lakartidningen; 1999 May; 96(18):2196. PubMed ID: 10377656
    [No Abstract]   [Full Text] [Related]  

  • 9. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estrogen-gestagen substitution in geriatric gynecology. Long-term prevention for the third segment of life after menopause].
    Lauritzen C
    Fortschr Med; 1996 May; 114(15):187-90. PubMed ID: 8767936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: hormone replacement therapy and coronary heart disease: four lessons.
    Petitti D
    Int J Epidemiol; 2004 Jun; 33(3):461-3. PubMed ID: 15166191
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen replacement therapy (ERT) and hormone replacement therapy (HRT) in the prevention of cardiovascular diseases.
    Nikolov R; Golbs S; Schneider HP
    Zentralbl Gynakol; 1999; 121(2):101-4. PubMed ID: 10096179
    [No Abstract]   [Full Text] [Related]  

  • 15. [The Danish Nurse Cohort Study 1993-2003].
    Hundrup YA; Obel EB; Rasmussen NK; Grønbaek M
    Ugeskr Laeger; 2004 Apr; 166(15-16):1451-4. PubMed ID: 15146817
    [No Abstract]   [Full Text] [Related]  

  • 16. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

  • 17. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 19. Current trends in hormone replacement therapy.
    Khashoggi TY
    Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk of breast cancer: the role of progestins.
    Stahlberg C; Pedersen AT; Lynge E; Ottesen B
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.